Affordable Access

Publisher Website

Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin

Diabetes Care
American Diabetes Association
Publication Date
DOI: 10.2337/dc09-9034
  • Editorials
  • Editorial
  • Medicine


Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin The worldwide epidemic of type 2 di-abetes continues unabated. Despiteextensive efforts to educate provid- ers, patients, and even the public at large as to the advantages of early identification and treatment to prevent complications, a large number of patients remain undiag- nosed. A serious barrier to an enhanced detection of diabetes has been inadequate screening using tests somewhat inconve- nient to patients and clinicians and there- fore often not optimally implemented. In this issue of Diabetes Care, a joint Ameri- can Diabetes Association, International Diabetes Federation, and European Asso- ciation for the Study of Diabetes Interna- tional Expert Committee examines diagnostic testing for diabetes, specifi- cally, the role of A1C, and makes signifi- cant new recommendations. While this report has not yet been endorsed as a guideline by either of the associations (or other organizations), it does represent a step in that direction and thus deserves attention. Clearly, no clinical diagnostic test is perfect. However, to be clinically useful, a test must be accurate, specific, standard- ized (or easily standardizable), handy, and, ideally, inexpensive. While plasma glucose testing meets some of these crite- ria, its use has been dogged by the need to obtain a sample in the fasting state (most people attend their outpatient visits in the fed state) or under standard carbohydrate challenge conditions, i.e., the oral glucose tolerance test. There also continues to be a degree of uncertainty concerning the di- agnostic performance of fasting glucose testing versus that of the oral glucose tolerance test—the latter done rarely in clinical practice for obvious reasons: in- convenience and cost. In addition, con- siderable variability not only in 2-h postglucose load values but also in fasting glucose has been a problem. Appropri- ately, clinicians have long wondered why they cannot use another diagnostic index, such a

There are no comments yet on this publication. Be the first to share your thoughts.